Snehal S. Patel

CEO
Greenwich LifeSciences
(NASDAQ: GLSI)

Mr. Patel has over 30 years of experience in executive management, corporate development, operations, and investment banking in the healthcare industry.  He has served as a consultant, manager, and advisor for R&D and manufacturing design, scale-up, and operations at multiple public and private biotech companies, working on clinical and pre-clinical assets in stem cell therapy, multiple sclerosis t-cell therapy, oncolytic viruses, and disposable biotech manufacturing equipment.  Mr. Patel has also served as an investment banker at Sanders Morris Harris, Ferghana Partners, and JP Morgan Chase, where he focused on healthcare and biotech financing and strategic transactions.  Prior to that, he worked in operations and business development at consulting firms and Bayer Corporation. 

He received a BS in Chemical Engineering and an MS in Biochemical Engineering from the Massachusetts Institute of Technology, a Certificate in Project Management from the University of California at Berkeley, and an MBA from the University of Chicago.